Free Trial

Bowie Capital Management LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Bowie Capital Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 22.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 210,165 shares of the healthcare conglomerate's stock after purchasing an additional 38,107 shares during the period. UnitedHealth Group accounts for approximately 5.6% of Bowie Capital Management LLC's portfolio, making the stock its 4th biggest position. Bowie Capital Management LLC's holdings in UnitedHealth Group were worth $106,314,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.9 %

Shares of NYSE:UNH traded down $3.46 during midday trading on Wednesday, hitting $391.05. The company had a trading volume of 8,514,401 shares, compared to its average volume of 4,667,653. UnitedHealth Group Incorporated has a 12 month low of $385.87 and a 12 month high of $630.73. The firm has a fifty day simple moving average of $493.20 and a 200 day simple moving average of $526.12. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $355.95 billion, a price-to-earnings ratio of 25.23, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business earned $6.91 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on UNH shares. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $652.00 to $525.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Hsbc Global Res downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 22nd. Finally, Truist Financial decreased their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Four research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $596.86.

Get Our Latest Research Report on UNH

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines